Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|September 1, 1979
Mezlocillin and azlocillin: an evaluation of two new beta-lactam antibioticsC J Ellis, A M Geddes, P G Davey, et al.The American Journal of Cardiology|July 25, 1998
Results of percutaneous coronary angioplasty in patients <40 years of ageC J Ellis, J K French, H D White, et al.Journal of Virology|August 1, 1996
Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individualsQ Y Yao, R J Tierney, D Croom-Carter, et al.Thorax|September 1, 1992
Generation of cytolytic T cells in individuals infected by Mycobacterium tuberculosis and vaccinated with BCGA D Pithie, M Rahelu, D S Kumararatne, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansionM G Hanna, M B Davis, M G Sweeney, et al.Journal of Virology|August 1, 1996
Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individualsQ Y Yao, R J Tierney, D Croom-Carter, et al.The American Journal of Cardiology|April 4, 1998
Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severityJ K French, C J Ellis, B J Webber, et al.The New Zealand Medical Journal|April 25, 1997
Cardiac transplantation in New Zealand: eight years experienceM Lund, C J Ellis, H A Coverdale, et al.Clinical and Experimental Immunology|June 1, 1990
Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosisD S Kumararatne, A S Pithie, P Drysdale, et al.BMJ (Clinical Research Ed.)|June 29, 1996
Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarctionJ K French, B F Williams, H H Hart, et al.Pageof 8